Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA approves new COVID booster amid rising cases, hospitalizations

Por: ABC News Health September 12, 2023

thumbnail

The U.S. Food and Drug Administration updated COVID boosters on Monday amid across the country.The boosters made by Pfizer-BioNTech and Moderna, were formulated to target variants that are currently circulating, which are related to XBB – an offshoot of the omicron variant.Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death, Dr. Peter Marks,... + full article



Similar News

COVID hospitalizations increase for 7th consecutive week but new boosters could help

ABC News USA Health September 07, 2023

thumbnailCOVID-19 hospitalizations are but there is hope that the uptick could be stemmed with the new boosters.Hospitalizations increased 15.7% for the week ending Aug. 26 from 15,050 to 17,418, according to .These are similar to levels seen in late March of this year and it marks the... + más

High school scores and top performers from Friday, March 24 | Orlando Sentinel

High school scores and top performers from Tuesday, March 28 | Orlando Sentinel


Moderna's Omicron Booster Works Against New Variants, Company Says

Time USA Health November 14, 2022

thumbnailIn a news published Nov. 14, Moderna said its updated Omicron booster shot targeting the variants BA.4 and BA.5 produced higher levels of antibodies against those versions of the virus than its original shot did. Compared to Moderna’s original booster, the Omicron booster... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Here’s Why Experts Believe the New Omicron Booster Will Work | Time


Goldman Sachs just dropped the names of its biggest partner class since David Solomon took over as CEO. See the full list here.

Business Insider USA Business November 09, 2022

thumbnailGoldman Sachs promoted 80 people to partner status on Wednesday, marking the largest class since David Solomon took over as CEO in 2018.Twenty-three of the new members are women and seven identify as black — the highest ever figures in both cases, the company said. Nineteen... + más

Goldman Sachs insiders say they are concerned about CEO David Solomon's push to build his personal brand, pointing to staff help for his DJing and use of the firm's planes | Business Insider

Who's up and who's down in the latest Goldman Sachs restructuring under CEO David Solomon | Business Insider


Bivalent booster is 4x better against BA.5 in older adults, Pfizer says

Ars Technica USA Science November 05, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Nov 4, 2022 9:26 pm UTC Share this story The new bivalent COVID-19 booster spurred neutralizing antibody levels that were... + más

Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant | ABC News

Here’s Why Experts Believe the New Omicron Booster Will Work | Time


11.5M Americans have received updated COVID booster: CDC

ABC News USA Health October 12, 2022

thumbnailAbout 11.5 million Americans have received the updated bivalent COVID-19 booster, according to from the Centers for Disease Control and Prevention.The booster was rolled out at the beginning of September with the Pfizer booster approved for those aged 12 and older and the... + más

Thousands of Maine people per day getting their booster doses | Portland Press Herald

4.4 million Americans have received an updated bivalent COVID-19 booster | ABC News


Here’s Why Experts Believe the New Omicron Booster Will Work

Time USA Health September 24, 2022

thumbnailA published Sept. 16 in the New England Journal of Medicine (NEJM) makes a strong case for an Omicron-based COVID-19 booster shot. But first, a caveat: There are no data available yet demonstrating the effectiveness of the new Omicron booster on Aug. 31, which protects against... + más

Moderna-backed mouse study offers first head-to-head BA.5, BA.1 booster data | Ars Technica

Here’s How Effective the Original Vaccines Are Against Omicron | Time


Moderna-backed mouse study offers first head-to-head BA.5, BA.1 booster data

Ars Technica USA Science September 19, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Sep 14, 2022 11:23 pm UTC Share this story In mice, the BA.5-targeting bivalent booster now rolling out nationwide did an... + más

US clears updated COVID boosters targeting newest variants | ABC News

US clears updated COVID boosters targeting newest variants | 10 WBNS



About iurex | Privacy Policy | Disclaimer |